Canopy Growth Corporation (TSE:WEED): Desjardins Reaffirms Hold Rating Today, Has a Target …

Desjardins now has a $63 target on shares of Canopy Growth Corporation (TSE:WEED). The target gives a potential upside of 20.11 % from the …

Canopy Growth Corporation (TSE:WEED) Rating Reaffirmed

Desjardins now has a $63 target on shares of Canopy Growth Corporation (TSE:WEED). The target gives a potential upside of 20.11 % from the current price of Canopy Growth Corporation (TSE:WEED). This rating was revealed to clients and investors in a research report on Monday morning.

Canopy Growth Corporation (TSE:WEED) Ratings Coverage

Among 4 analysts covering Canopy Growth Corporation (TSE:WEED), 2 have Buy rating, 0 Sell and 2 Hold. Therefore 50% are positive. Canopy Growth Corporation has $75 highest and $63 lowest target. $68’s average target is 29.65% above currents $52.45 stock price. Canopy Growth Corporation had 13 analyst reports since February 15, 2019 according to SRatingsIntel. The stock of Canopy Growth Corporation (TSE:WEED) has “Buy” rating given on Tuesday, February 19 by IBC. The firm has “Hold” rating given on Monday, March 4 by Jefferies. The rating was initiated by Jefferies with “Hold” on Monday, February 25. The rating was maintained by Desjardins Securities on Monday, June 24 with “Hold”. The stock has “Buy” rating by Canaccord Genuity on Tuesday, February 19.

The stock decreased 2.02% or $1.08 during the last trading session, reaching $52.45. About 1.19M shares traded. Canopy Growth Corporation (TSE:WEED) has 0.00% since June 26, 2018 and is . It has underperformed by 4.43% the S&P500.

Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. The company has market cap of $18.14 billion. The Company’s products include dried flowers, oils and concentrates, softgel capsules, and hemps. It currently has negative earnings. The firm offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, Bedrocan Canada, CraftGrow, and Foria brand names.

More notable recent Canopy Growth Corporation (TSE:WEED) news were published by: Profitconfidential.com which released: “Neptune Wellness Solutions Inc Shares Soar as This Weed Stock Enters New Growth Trajectory – Profit Confidential” on June 13, 2019, also Profitconfidential.com with their article: “Flowr Corp: Overlooked Cannabis Player Poised to Double Again in 2019 – Profit Confidential” published on June 07, 2019, Profitconfidential.com published: “WeedMD Inc: Under-the-Radar $1.35 Pot Stock Set to Double – Profit Confidential” on June 03, 2019. More interesting news about Canopy Growth Corporation (TSE:WEED) were released by: Midasletter.com and their article: “3 Sixty Secure Corp (CNSX:SAFE) Cannabis Security Provider Generating $2.4M in Monthly Revenue – Midas Letter” published on June 03, 2019 as well as Midasletter.com‘s news article titled: “Canopy Growth Corp (TSE:WEED) Allocating $1 Billion Towards New Acquisitions – Midas Letter” with publication date: November 15, 2018.

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Related Posts:

  • No Related Posts

Desjardins Maintains The “Hold” Rating They’ve had for Canopy Growth Corp (CGC) Shares

Desjardins kept their “Hold” rating on Canopy Growth Corp (CGC) in analysts note shared with investors on Monday, 24 June.

Canopy Growth Corp (CGC) Rating Reaffirmed

Desjardins kept their “Hold” rating on Canopy Growth Corp (CGC) in analysts note shared with investors on Monday, 24 June.

Canopy Growth Corporation (NYSE:CGC) Ratings Coverage

Among 3 analysts covering Canopy Growth (CGC), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Canopy Growth has $60 highest and $40 lowest target. $58.67’s average target is 47.52% above currents $39.77 stock price. Canopy Growth had 16 analyst reports since January 9, 2019 according to SRatingsIntel. The stock of Canopy Growth Corporation (NYSE:CGC) earned “Buy” rating by Piper Jaffray on Friday, June 21. As per Friday, January 25, the company rating was maintained by PiperJaffray. On Friday, June 21 the stock rating was maintained by Bank of America with “Buy”. The stock of Canopy Growth Corporation (NYSE:CGC) has “Buy” rating given on Monday, March 4 by Piper Jaffray.

The stock decreased 1.97% or $0.8 during the last trading session, reaching $39.77. About 3.36 million shares traded. Canopy Growth Corporation (CGC) has risen 79.80% since June 26, 2018 and is uptrending. It has outperformed by 75.37% the S&P500.

Analysts await Canopy Growth Corporation (NYSE:CGC) to report earnings on August, 13. They expect $-0.17 earnings per share, up 45.16 % or $0.14 from last year’s $-0.31 per share. After $-0.67 actual earnings per share reported by Canopy Growth Corporation for the previous quarter, Wall Street now forecasts -74.63 % EPS growth.

Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. The company has market cap of $13.67 billion. The Company’s products include dried flowers, oils and concentrates, softgel capsules, and hemps. It currently has negative earnings. The firm offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, Bedrocan Canada, CraftGrow, and Foria brand names.

More notable recent Canopy Growth Corporation (NYSE:CGC) news were published by: Finance.Yahoo.com which released: “Stock Market News: Pot Losses Hit Constellation Brands; Medtronic Delivers Dividends – Yahoo Finance” on June 21, 2019, also Finance.Yahoo.com with their article: “Hedge Funds Have Never Been More Bullish On Darden Restaurants, Inc. (DRI) – Yahoo Finance” published on June 07, 2019, Prnewswire.com published: “Canopy Rivers announces grant of options – PRNewswire” on June 13, 2019. More interesting news about Canopy Growth Corporation (NYSE:CGC) were released by: Benzinga.com and their article: “With Legalization, Illinois Leaps Headlong Into The Industrial Hemp Market – Benzinga” published on June 13, 2019 as well as Seekingalpha.com‘s news article titled: “FDA to host public hearing on cannabis Friday – Seeking Alpha” with publication date: May 29, 2019.

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Related Posts:

  • No Related Posts

Reaffirmed: Canopy Growth Corporation (TSE:WEED) “Hold” Rating Kept by Analysts at Desjardins …

Canopy Growth Corporation (TSE:WEED) just had their share rating of a ‘”Hold”’ issued by research analysts at Desjardins, who now has a $63 target …

Canopy Growth Corporation (TSE:WEED) Rating Reaffirmed

Canopy Growth Corporation (TSE:WEED) just had their share rating of a ‘”Hold”‘ issued by research analysts at Desjardins, who now has a $63 target on the $18.14 billion market cap company or a 20.11 % upside potential. This key information was disclosed to clients in analysts note on 24 June.

Canopy Growth Corporation (TSE:WEED) Ratings Coverage

Among 4 analysts covering Canopy Growth Corporation (TSE:WEED), 2 have Buy rating, 0 Sell and 2 Hold. Therefore 50% are positive. Canopy Growth Corporation has $75 highest and $63 lowest target. $68’s average target is 29.65% above currents $52.45 stock price. Canopy Growth Corporation had 13 analyst reports since February 15, 2019 according to SRatingsIntel. The company was maintained on Monday, March 4 by Jefferies. IBC maintained the shares of WEED in report on Tuesday, February 19 with “Buy” rating. Jefferies initiated it with “Hold” rating and $64 target in Monday, February 25 report. On Tuesday, February 19 the stock rating was maintained by Canaccord Genuity with “Buy”. Desjardins Securities maintained the shares of WEED in report on Monday, June 24 with “Hold” rating.

The stock decreased 2.02% or $1.08 during the last trading session, reaching $52.45. About 1.19 million shares traded. Canopy Growth Corporation (TSE:WEED) has 0.00% since June 26, 2018 and is . It has underperformed by 4.43% the S&P500.

Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. The company has market cap of $18.14 billion. The Company’s products include dried flowers, oils and concentrates, softgel capsules, and hemps. It currently has negative earnings. The firm offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, Bedrocan Canada, CraftGrow, and Foria brand names.

More notable recent Canopy Growth Corporation (TSE:WEED) news were published by: Seekingalpha.com which released: “Cannabis Stocks On The TSX – Seeking Alpha” on October 31, 2018, also Midasletter.com with their article: “Canopy Growth Corp (TSE:WEED) Straddling 200-Day MA As Sector Weakness Abounds – Midas Letter” published on November 20, 2018, Midasletter.com published: “Canopy Growth Corp (TSE:WEED) 50-Day MA Failure Triggers Industry-Wide Selling Event – Midas Letter” on April 03, 2018. More interesting news about Canopy Growth Corporation (TSE:WEED) were released by: Midasletter.com and their article: “Auorua Cannabis Inc (TSE:ACB), Canopy Growth Corp (TSE:WEED), Aphria Inc (TSE:APH), MedReleaf Corp: Canada Cannabis Roundup – Midas Letter” published on April 16, 2018 as well as Midasletter.com‘s news article titled: “Canopy Growth Corp (TSE:WEED) Displaying Relative Strength Following Big Apple Presentation – Midas Letter” with publication date: May 18, 2018.

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Related Posts:

  • No Related Posts

Why BMO Capital Has Just Restated Their Hold Rating For Canopy Growth Corp (CGC) Shares

Canopy Growth Corp (CGC) has had their stock rating noted as a solid Hold by expert analysts at BMO Capital. This was shown in an analyst note on …

Canopy Growth Corp (CGC) Rating Reaffirmed

Canopy Growth Corp (CGC) has had their stock rating noted as a solid Hold by expert analysts at BMO Capital. This was shown in an analyst note on Monday morning.

Canopy Growth Corporation (NYSE:CGC) Ratings Coverage

Among 3 analysts covering Canopy Growth (CGC), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Canopy Growth has $60 highest and $40 lowest target. $58.67’s average target is 47.34% above currents $39.82 stock price. Canopy Growth had 16 analyst reports since January 9, 2019 according to SRatingsIntel. The stock of Canopy Growth Corporation (NYSE:CGC) earned “Overweight” rating by PiperJaffray on Friday, January 25. The firm earned “Buy” rating on Monday, March 4 by Piper Jaffray. Piper Jaffray maintained Canopy Growth Corporation (NYSE:CGC) on Friday, June 21 with “Buy” rating. Bank of America maintained it with “Buy” rating and $56 target in Friday, June 21 report.

The stock decreased 1.85% or $0.75 during the last trading session, reaching $39.82. About 3.09M shares traded. Canopy Growth Corporation (CGC) has risen 79.80% since June 25, 2018 and is uptrending. It has outperformed by 75.37% the S&P500.

Analysts await Canopy Growth Corporation (NYSE:CGC) to report earnings on August, 13. They expect $-0.17 EPS, up 45.16 % or $0.14 from last year’s $-0.31 per share. After $-0.67 actual EPS reported by Canopy Growth Corporation for the previous quarter, Wall Street now forecasts -74.63 % EPS growth.

Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. The company has market cap of $13.69 billion. The Company’s products include dried flowers, oils and concentrates, softgel capsules, and hemps. It currently has negative earnings. The firm offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, Bedrocan Canada, CraftGrow, and Foria brand names.

More notable recent Canopy Growth Corporation (NYSE:CGC) news were published by: Finance.Yahoo.com which released: “2 Billionaires Just Bought Aurora Cannabis Stock — Should You? – Yahoo Finance” on May 29, 2019, also Fool.com with their article: “3 Pot Stocks That Have Left Aurora Cannabis Eating Their Dust Since the Beginning of 2018 – Motley Fool” published on June 03, 2019, Fool.com published: “Is Cronos Group a Buy? – The Motley Fool” on June 01, 2019. More interesting news about Canopy Growth Corporation (NYSE:CGC) were released by: Finance.Yahoo.com and their article: “The 5 Most Profitable Pot Stocks on the Planet – Yahoo Finance” published on June 16, 2019 as well as Seekingalpha.com‘s news article titled: “CURE Pharmaceutical, Canopy Growth to make CBD oral thin films – Seeking Alpha” with publication date: June 19, 2019.

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Related Posts:

  • No Related Posts

Canopy Growth Corp (CGC) “Hold” Rating Has Just Been Reiterated by BMO Capital

BMO Capital reaffirmed their “Hold” rating on Canopy Growth Corp (CGC) shards via analysts report sent to investors and clients on Monday, 24 June.

Canopy Growth Corp (CGC) Rating Reaffirmed

BMO Capital reaffirmed their “Hold” rating on Canopy Growth Corp (CGC) shards via analysts report sent to investors and clients on Monday, 24 June.

Canopy Growth Corporation (NYSE:CGC) Ratings Coverage

Among 3 analysts covering Canopy Growth (CGC), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Canopy Growth has $60 highest and $40 lowest target. $58.67’s average target is 47.34% above currents $39.82 stock price. Canopy Growth had 16 analyst reports since January 9, 2019 according to SRatingsIntel. Bank of America maintained Canopy Growth Corporation (NYSE:CGC) rating on Friday, June 21. Bank of America has “Buy” rating and $56 target. Piper Jaffray maintained Canopy Growth Corporation (NYSE:CGC) rating on Friday, June 21. Piper Jaffray has “Buy” rating and $60 target. The stock has “Buy” rating by Piper Jaffray on Monday, March 4. PiperJaffray maintained the stock with “Overweight” rating in Friday, January 25 report.

The stock decreased 1.85% or $0.75 during the last trading session, reaching $39.82. About 3.09 million shares traded. Canopy Growth Corporation (CGC) has risen 79.80% since June 25, 2018 and is uptrending. It has outperformed by 75.37% the S&P500.

Analysts await Canopy Growth Corporation (NYSE:CGC) to report earnings on August, 13. They expect $-0.17 EPS, up 45.16 % or $0.14 from last year’s $-0.31 per share. After $-0.67 actual EPS reported by Canopy Growth Corporation for the previous quarter, Wall Street now forecasts -74.63 % EPS growth.

Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. The company has market cap of $13.69 billion. The Company’s products include dried flowers, oils and concentrates, softgel capsules, and hemps. It currently has negative earnings. The firm offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, Bedrocan Canada, CraftGrow, and Foria brand names.

More notable recent Canopy Growth Corporation (NYSE:CGC) news were published by: Fool.com which released: “These Billion-Dollar Pot Stocks Are Buyout Candidates – The Motley Fool” on June 21, 2019, also Fool.com with their article: “3 Pot Stocks That Have Left Aurora Cannabis Eating Their Dust Since the Beginning of 2018 – Motley Fool” published on June 03, 2019, Benzinga.com published: “‘We’re Trying To Be Smart About It’: New Canopy Growth CFO Says Cannabis Company Eyeing Financing Options – Benzinga” on June 11, 2019. More interesting news about Canopy Growth Corporation (NYSE:CGC) were released by: Fool.com and their article: “Marijuana Stocks: You’re Missing 2 Key Points About International Expansion – The Motley Fool” published on June 08, 2019 as well as Fool.com‘s news article titled: “A Completely Unknown Pot Stock Aims to Be Canada’s Third-Largest Cannabis Grower – The Motley Fool” with publication date: May 30, 2019.

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Related Posts:

  • No Related Posts